Strive reported net income of $509 million for the third quarter of 2026, compared with a net loss of about $207 million in the same period last year. According to Foresight News, the bitcoin treasury company disclosed in a filing with the U.S. Securities and Exchange Commission that the profit primarily reflected about $534 million in noncash unrealized gains on bitcoin.
Revenue rose 74.7% year over year to $2.696 million, mainly due to medical device business revenue added after Strive completed its merger with Semler Scientific earlier in the year. During the quarter, the company ended a medical device research and development project and recorded a $14.65 million impairment. As of September 30, it had $285 million in cash and cash equivalents.
Strive bought 8,136 bitcoin during the quarter at an average price of $78,885. As of September 30, it held 28,000 bitcoin.
In the quarter, Strive raised $272 million by selling 14.4 million Class A common shares through its at-the-market program and $511 million from the sale of 5.1 million SATA preferred shares. On October 20, it completed a public offering of 7 million SATS preferred shares, generating net proceeds of about $609 million.